Last updated on May 2019

An Open-Label Phase 2 Study of INCB050465 in Participants With Primary Sjögren's Syndrome

Brief description of study

To determine the impact of INCB050465 on the signs and symptoms of Sjögren's syndrome (SS). To evaluate the safety and tolerability of INCB050465.

Clinical Study Identifier: TX220943

Find a site near you

Start Over

Ramesh C. Gupta, M.D.

Located in: Memphis, Tn United States
  Connect »

Advanced Pharma CR, LLC

Located in: Miami, FL United States
  Connect »

North Georgia Rheumatology Group

Located in: Lawrenceville, GA United States
  Connect »

The Center for Rheumatology and Bone Research

Located in: Wheaton, MD United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.